Wednesday, May 11, 2022

Alembic Pharma gets final USFDA nod for generic version of Arformoterol Tartrate inhalation solution

Alembic Pharma gets final USFDA nod for generic version of Arformoterol Tartrate inhalation solution The approval by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Arformoterol Tartrate inhalation solution is for strength of 15 mcg (base)/2 mL unit-dose vial, the company said in a statement.

from Moneycontrol Business News https://ift.tt/fGPwVTQ
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...